2.Advocating for general practice in China
Chinese Journal of General Practitioners 2016;15(1):17-18
@@
3.Comprison of the Cost-effectiveness Between Granisetron and Ondansetron in Preventing Nausea and Vomiting Caused by Cancer Chemotherapy
Jun PANG ; Fei LI ; Binghui YANG
China Pharmacy 1991;0(01):-
OBJECTIVE:To compare the therapeutic effect,adversere reactions and cost-effectiveness between granisetron and ondansetron in preventing nausea and vomiting caused by cancer chemotherapy.METHODS:Using pharmacoeconomic co_st-effectiveness analysis,the relevant therapeutic indices were evaluated.RESULTS:The effective rates of granisetron in preventing nausea and vomiting were 83.6% and 86.8% with an average cost of 210.48 yuans in a therapeutic couse,the cost-ef_fective ratio being 251.77 and 242.37,and those of ondansetron were 72.9% and 83.7% with an average cost of 381.35 yuans,the cost-effective ratio being 523.11 and 456.62.CONCLUSION:Granisetron can effectively prevent nausea and vomiting caused by cancer chemotherapy,and its cost-effective ratio is superior to that of ondansetron.
4.HPLC Determination of Baicalin in Jian' er Xiaosi Oral Liquid
Jinfei LI ; Binghui ZHU ; Yang LI
Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(03):-
Objective To establish a method for the content determination of baicalin in Jian' er Xiaosi Oral Liquid.Method A HPLC method was adopted.The chromatography conditions were as follows:Prodigy ODS(150 mm? 4.6 mm,5 ? m)served as stationary phase and methanol-water-glacial acetic acid(v/v,47:53:1.5)as mobile phase,the detection wavelength was 280 nm,column temperature 35 ℃ and flow rate 1.2 mL/min.Results The amount of inlet baicalin had a good linearity with the response value of peak area in the range of 0.284~ 3.540 ? g,r=0.999 9.The average recovery of baicalin was 100.33 % and RSD was 0.58 %(n=6).Conclusion This method is simple,rapid,reliable,reproducible,and can be used for the quality control of Jian' er Xiaosi Oral Liquid.
5.Study on the method for relieving fingertip pain in monitoring fingertip blood glucose
Binghui LI ; Chao ZHANG ; Meng YANG ; Fanghua ZHANG
Chinese Journal of Geriatrics 2013;32(12):1294-1296
Objective To explore the method to relieve fingertip pain in monitoring fingertip blood glucose.Methods A total of 130 newly admitted patients with type 2 diabetes received glucose monitoring 6 times daily at different time points.Blood sampling was taken from different sites including the central and top of middle finger pulp,central and side of ring finger pulp,top of middle finger with pressing the acupoint of Hegu at the same time or pressing acupoint of Hegu for 1 minute before blood taking.Pain degree was assessed by numeric rating scale after blood glucose taking.Pain scores were compared among the different methods.Results There were significant differences in pain scores between different methods (x2 =164.83,P<0.05).Pain score was higher in sampling blood on the side of ring finger pulp,while the proportion of subjects with mild pain after pressing Hegu was increased significantly.There were significant differences in pain scores between subjects with versus without pressing Hegu (all P<0.05).Pain degree was reduced more significantly by pressing Hegu for 1 minute before blood taking than pressing Hegu at the same time of sampling blood,and the former had a higher proportion of subjects with only mild pain than the latter (x2 =10.44,P<0.01).There were no significant differences in pain scores between the other methods (all P> 0.05).Conclusions Pressing Hegu can effectively reduce fingertip pain in fingertip blood glucose monitoring,and pressing Hegu for 1 minute before blood taking is more effective.
6.Characteristics of optical coherence tomography angiography in nonarteritic anterior ischemic optic neuropathy patients
Binghui WU ; Yan SUO ; Yang QIAO ; Chan LI ; Jinxin SONG ; Huiqin LU
Journal of Chinese Physician 2021;23(5):645-649
Objective:To analyze the superficial retinal blood flow around the optic disc of optical coherence tomography angiography (OCTA) in non-arteritic anterior ischemic optic neuropathy (NA-AION) patients with affected eyes and contralateral healthy eyes, compared with healthy people.Methods:From May 2018 to may 2019, 30 patients with NA-AION in Xi′an No. 1 Hospital were selected. The changes of superficial retinal blood flow density and perfusion around the optic disc on OCTA of 30 patients with NA-AION, whose contralateral healthy eyes were compared. The pattern visual evoked potential (PVEP) of both eyes was also compared. 30 healthy people with no history of eye disease and history of eye surgery were selected as healthy control group, and differences between healthy control group and contralateral healthy eye group in NA-AION patients of the superficial retinal blood flow density and perfusion around the optic disc were compared.Results:The average values of serum homocysteine, apolipoprotein E and low density lipoprotein in 30 patients with NA-AION were higher than the normal reference range. Compared with the contralateral healthy eyes, the effected eyes of NA-AION patients had lower retinal blood flow density and perfusion in the center, inner layer and complete area of the optic disc, with significantly difference ( P<0.05); there was no significant difference in the latency and amplitude of PVEP-P100 between the two groups ( P>0.05). There was no significant difference in the density and perfusion of superficial retinal blood flow in the center, inner layer and complete area of the optic disc between the contralateral healthy eyes of NA-AION patients and healthy control ( P>0.05). Conclusions:OCTA is a safe, rapid and non-invasive test, and it can detect blood perfusion defects promptly, which can be used as the most commonly test method for patients with NA-AION in order to make auxiliary diagnosis and gain time for clinical treatment.
7.Feasibility and safety of percutaneous cryoablation for locally advanced pancreatic cancer
Lizhi NIU ; Haibo LI ; Weifeng WEN ; Yong HU ; Binghui WU ; Bing LIANG ; Rongrong LI ; Liang ZHOU ; Jing WANG ; Daming YANG ; Kecheng XU
Chinese Journal of Pancreatology 2011;11(1):1-4
Objective To observe the adverse reaction, tumor response and short term outcomes of percutaneous cryoablation for locally advanced pancreatic cancer, and investigate its feasibility. Methods Fifty-nine consecutive patients with locally advanced, unresectable pancreatic cancer underwent percutaneous cryoablation at our hospital from Sept. 2008 to Sept. 2009, were prospectively studied. Percutaneous cryoablation was performed with an argon/helium-based cryosurgical system under the guidance of ultrasound.Freezing probe was inserted into the center of pancreatic mass and two cycles of freezing were performed with each cycle for 5 min and temperature at-160℃, then the temperature was returned to normal for 10 min.Serum amylase was detected before operation and 1 to 7 days postoperatively. CT or PET-CT scanning was performed for evaluation of tumor response every 4 to 6 weeks after cryoablation. Survival was assessed by Kaplan-Meier method. Results 59 patients had a total of 76 biopsy-proven tumors, which were located at the pancreas head (n = 56), body (n = 7), and tail (n = 13). The median size of tumor was 4.5 cm (range 3 ~6 cm). Nineteen patients had liver metastases. Postoperative abdominal pain occurred in 45 cases (76.3%),fever occurred in 29 cases (49.2%) and elevation of serum amylase occurred in 34 cases (57.6%). Severe complications including intra-abdominal bleeding, pancreatic leaks, ileus, and metastasis by probe tract occurred in 5 cases (8.5%). There was no death associated with cryoablation. The median hospital stay was 21 days. 2 patients (3.4%) achieved complete response, 23 patients (39.0%) achieved partial response,30patients (50.8%) had stable disease, 4 patients(6.8%) had progressive disease. The median survival was 8.4 months. The overall survival at 3, 6 and 12 months was 89.7%, 61.1% and 34.5%, respectively.Conclusions Ultrasound-guided percutaneous cryoablation appears to be a safe and feasible, minimally invasive technique for locally advanced pancreatic cancer.
8.Characteristics of hepatitis C virus infection and genotype distribution among entry travelers at Tengchong Port
Shuting YANG ; Yuebo LIANG ; Binghui WANG ; Zhongsheng HOU ; Ye XU ; Qicai XUAN ; Dingyuan LI ; Weihong QIN ; Xueshan XIA
Chinese Journal of Infectious Diseases 2017;35(10):612-616
Objective To investigate the characteristics of epidemic and genotype/subtype distribution of hepatitis C virus (HCV) among entry travelers at Tengchong port,to provide references for HCV prophylaxis and treatment.Methods A total of 54 serum samples were collected from anti-HCV positive travelers at Tengchong port from June 2009 to June 2016.HCV NS5B gene was amplified using reverse transcription polyonerase chain reation (RT-PCR) and subsequently sequenced.Based on the obtained sequences and retrieved reference sequences,phylogenetic analysis was conducted to determine HCV genotype/subtype.Results HCV infection rate among entry travelers at Tengchong ports was 0.45 % (54/12 059).Forty five samples were successfully genotyped.Phylogenetically,HCV genotype 3b was revealed to be the predominant subtype (28.89 %,13/45) in this population,followed by genotype 6n (20.0%,9/45),genotype 1b (17.78%,8/45),genotype 3a (13.33%,6/45),genotype 2a (11.11%,5/45),genotype 1a (2.22%,1/45) and genotype 6a (2.22%,1/45).The major genotype in Myanmar travelers was genotype 6,while in Chinese population,genotype 1 predominated.Genotype 6 in the population showed close phylogenetic relationship with strains prevalent in China and Southeast Asia.Genotype 3 was closely clustered with strains prevalent in China.Conclusions The distribution of HCV genotypes among entry travelers at Tengchong port is impacted by HCV epidemic strains both in Yunnan province and neighboring regions.This population serves as a transmitting media which may influence the epidemiological characteristics of HCV in Tengchong and neighboring areas.
9.Extrapedicular unilateral percutaneous vertebroplasty via transverse process for osteoporotic vertebral compression fractures of upper lumbar
Yugang LIU ; Binghui WANG ; You LONG ; Yang LI ; Yongjian GAO ; Hui LIANG ; Dianming JIANG
Chinese Journal of Trauma 2018;34(4):312-318
Objective To investigate the effect of transverse extrapedicular unilateral percutaneous vertebroplasty (PVP) via transverse process in treating the osteoporotic vertebral compression fractures.Methods A retrospective study was performed on 16 patients with osteoporotic vertebral compression fractures of upper lumbar treated from August 2016 through December 2016.There were seven males and nine females,at a mean age of 73.5 years (range,62-90 years).All the patients reported severe back pain,with an average history of 2 weeks (range,1-24 weeks).MRI confirmed the diagnosis of osteoporotic vertebral compression fractures,and the compression degree of the affected vertebral body was (25.4 ± 5.3) %.All the patients were treated with extrapedicular unilateral PVP via transverse process under local anesthesia.The operation time,fluoroscopy frequency,bone cement injection volume,and bone cement dispersion were recorded.Back pain and function recovery were assessed by visual analogue scale (VAS) and Oswestry disability index (ODI),respectively.Results All patients were followed up for 6-12 months (mean,8 months).All operations were successful without complications.The average operation time was 20 min (range,15-30 minutes),and there were 3-6 times of fluoroscopy with successful incubation.The average volume of bone cement injected to each injured vertebral body was 6.2 ml (range,5-9 m1).The bone cement dispersed satisfactorily in the vertebral body.Complete relief of lumbar and back pain was achieved in 14 patients,and remarkable relief in two patients.The postoperative VAS and ODI at 24 hours,72 hours,and 6 months were significantly lower than those before operation (P <0.01).Conclusion Extrapedicular unilateral percutaneous vertebroplasty via transverse process has the advantages of uniform fractured bone cement perfusion,significant pain relief,and rapid recovery,and hence is a simple,safe and effective treatment for osteoporotic vertebral compression fractures of the upper lumbar vertebrae.
10.Effects of pretreatment with nicorandil on PDCD4/NF-κB/TNF-α pathway in coronary microembolization
Qiang SU ; Lang LI ; Yuhan SUN ; Ziliang YE ; Xuefei YANG ; Binghui KONG
Chinese Journal of Emergency Medicine 2018;27(10):1083-1088
Objective To investigate the role of nicorandil pretreatment on protecting myocardium after coronary microembolization (CME) and on the PDCD4/NF-κB/TNF-α signaling pathway in miniature pigs. Methods Fifteen Bama miniature pigs were randomly(random number) divided into the sham operation group (sham group), microembolization group (CME group) and CME plus nicorandil group, with 5 pigs in each group. The CME model was constructed by injecting polyethylene microspheres via microcatheter into the left anterior descending artery, and pigs in the sham group were injected with the same amount of saline. Pigs in the CME plus nicorandil group were injected intravenously with nicorandil (150 μg/kg) via ear vein 30 min before CME. Cardiac function indexes were measured using cardiac ultrasonography. The expression of PDCD4 and TNF-α mRNA in myocardium were detected by fluorescence quantitative PCR, and the protein expression of PDCD4 and TNF-α in myocardium were detected by Western blotting. NF-κB activation was evaluated by electrophoretic mobility shift assay. Results (1) Cardiac function was significantly lower and the level of serum cTnI was significantly higher in the CME group compared with the sham group. CME reduced myocardial systolic dysfunction and left ventricular dilatation. The CME plus nicorandil group showed improved CME-induced cardiac function and reduced serum cTnI level when compared with the CME Group (P < 0.05). (2) Compared with the CME group, the CME plus nicorandil group showed lower PDCD4 and TNF-α expression and NF-κB activity as well as improved cardiac function (P < 0.05). Conclusions The pretreatment of nicorandil effectively reduced the myocardial damage caused by CME, mainly through inhibiting the PDCD4/NF-κB/TNF-α pathway in cardiomyocytes.